330 related articles for article (PubMed ID: 1606583)
1. Idiopathic infantile hypercalcemia: rapid response to treatment with calcitonin.
Alon U; Berkowitz D; Berant M
Child Nephrol Urol; 1992; 12(1):47-50. PubMed ID: 1606583
[TBL] [Abstract][Full Text] [Related]
2. Increased serum calcitonin, reduced serum 1,25-(OH)2-vitamin D and normal parathormone concentrations in idiopathic hypercalciuria.
Lama G; Stile V; Ragone G; Meninno V; Senatore SN; Russo A; Lepore A; Scopacasa F; Iafusco D; Carbone A
Child Nephrol Urol; 1988-1989; 9(3):135-7. PubMed ID: 3252962
[TBL] [Abstract][Full Text] [Related]
3. Idiopathic infantile hypercalcemia discovered in the newborn period.
Shimizu H; Kodama S; Takeuchi A; Matui T; Nakao H; Sakurai T; Kobayashi T
Acta Paediatr Jpn; 1994 Dec; 36(6):720-3. PubMed ID: 7871992
[TBL] [Abstract][Full Text] [Related]
4. Citric acid concentration compared to serum parathyroid hormone, 1,25(OH)2D3 and calcitonin during dietary Ca deficiency and rehabilitation enhanced with xylitol in rats.
Svanberg M; Knuuttila M; Hämäläinen M
Miner Electrolyte Metab; 1993; 19(2):103-8. PubMed ID: 8377724
[TBL] [Abstract][Full Text] [Related]
5. Immobilization hypercalcemia associated with Landry-Guillain-Barré syndrome. Successful therapy with combined calcitonin and etidronate.
Meythaler JM; Korkor AB; Nanda T; Kumar NA; Fallon M
Arch Intern Med; 1986 Aug; 146(8):1567-71. PubMed ID: 3089187
[TBL] [Abstract][Full Text] [Related]
6. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
7. Infantile hypercalcemia and hypercalciuria: new insights into a vitamin D-dependent mechanism and response to ketoconazole treatment.
Nguyen M; Boutignon H; Mallet E; Linglart A; Guillozo H; Jehan F; Garabedian M
J Pediatr; 2010 Aug; 157(2):296-302. PubMed ID: 20394945
[TBL] [Abstract][Full Text] [Related]
8. Fluid and electrolyte disorders. Calcium.
Stevenson JC
Br J Hosp Med; 1984 Aug; 32(2):71-2, 75-6. PubMed ID: 6549532
[TBL] [Abstract][Full Text] [Related]
9. Calcium homeostasis.
Boden SD; Kaplan FS
Orthop Clin North Am; 1990 Jan; 21(1):31-42. PubMed ID: 2404236
[TBL] [Abstract][Full Text] [Related]
10. A case of resistant hypercalcemia of malignancy with a proposed treatment algorithm.
McMahan J; Linneman T
Ann Pharmacother; 2009 Sep; 43(9):1532-8. PubMed ID: 19622757
[TBL] [Abstract][Full Text] [Related]
11. Nephrocalcinosis in a 2-month-old girl suffering from a mild variant of idiopathic infantile hypercalcemia.
Zajadacz B; Juszkiewicz A
Wiad Lek; 2004; 57(11-12):710-2. PubMed ID: 15865256
[TBL] [Abstract][Full Text] [Related]
12. [Hypervitaminosis D. Review of fifteen cases].
Castelló F; Callís L; Nieto JL; Vilaplana E
An Esp Pediatr; 1979 Mar; 12(3):207-18. PubMed ID: 443641
[TBL] [Abstract][Full Text] [Related]
13. Mild infantile hypercalcemia: diagnostic tests and outcomes.
Koltin D; Rachmiel M; Wong BY; Cole DE; Harvey E; Sochett E
J Pediatr; 2011 Aug; 159(2):215-21.e1. PubMed ID: 21414629
[TBL] [Abstract][Full Text] [Related]
14. Vitamin D, parathormone, and calcitonin profiles in persons with long-standing spinal cord injury.
Vaziri ND; Pandian MR; Segal JL; Winer RL; Eltorai I; Brunnemann S
Arch Phys Med Rehabil; 1994 Jul; 75(7):766-9. PubMed ID: 8024422
[TBL] [Abstract][Full Text] [Related]
15. CYP3A4 Induction by Rifampin: An Alternative Pathway for Vitamin D Inactivation in Patients With CYP24A1 Mutations.
Hawkes CP; Li D; Hakonarson H; Meyers KE; Thummel KE; Levine MA
J Clin Endocrinol Metab; 2017 May; 102(5):1440-1446. PubMed ID: 28324001
[TBL] [Abstract][Full Text] [Related]
16. Biochemical indicators of disordered vitamin D and calcium homeostasis in sarcoidosis.
Adams JS; Gacad MA; Anders A; Endres DB; Sharma OP
Sarcoidosis; 1986 Mar; 3(1):1-6. PubMed ID: 3033783
[TBL] [Abstract][Full Text] [Related]
17. Increased renal calcium reabsorption by parathyroid hormone-related protein is a causative factor in the development of humoral hypercalcemia of malignancy refractory to osteoclastic bone resorption inhibitors.
Onuma E; Azuma Y; Saito H; Tsunenari T; Watanabe T; Hirabayashi M; Sato K; Yamada-Okabe H; Ogata E
Clin Cancer Res; 2005 Jun; 11(11):4198-203. PubMed ID: 15930357
[TBL] [Abstract][Full Text] [Related]
18. Treatment of acute lymphoblastic leukemia-induced extreme hypercalcemia with pamidronate and calcitonin.
Mathur M; Sykes JA; Saxena VR; Rao SP; Goldman GM
Pediatr Crit Care Med; 2003 Apr; 4(2):252-5. PubMed ID: 12749663
[TBL] [Abstract][Full Text] [Related]
19. Mineral homeostasis during lactation- relationship to serum 1,25-dihydroxyvitamin D, 25-hydroxyvitamin D, parathyroid hormone and calcitonin.
Greer FR; Tsang RC; Searcy JE; Levin RS; Steichen JJ
Am J Clin Nutr; 1982 Sep; 36(3):431-7. PubMed ID: 6896793
[TBL] [Abstract][Full Text] [Related]
20. Proceedings: Hypercalcemia in malignant bone diseases and its management. Studies on calcium metabolism and the use of calcitonin.
Takatsuki K; Yodoi J; Wakisaka G; Yamamoto I; Hamamoto K
Calcif Tissue Res; 1974; 15(2):157. PubMed ID: 4844394
[No Abstract] [Full Text] [Related]
[Next] [New Search]
